Study Details
A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects with Advanced Hepatocellular Carcinoma
Clinicaltrials.gov ID
Astellas Study ID
9785-CL-3021
EudraCT ID
2014-004283-37
Condition
Liver Cancer
Phase
Phase 2
Age
18 years - N/A
Sex
Female & Male
Product
enzalutamide
Type
Interventional
Trial Dates
Nov 2015 - Feb 2021
Masking
Double (Participant, Investigator)
Enrollment number
165
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Enzalutamide in Subjects with Advanced Hepatocellular Carcinoma
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects with Advanced Hepatocellular Carcinoma? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site KR82004
Seoul, Republic of Korea, 05505
Site US10017
Minneapolis, United States, 55455-0362
Site KR82002
Seongnam-Si, Republic of Korea, 013620
Site ES34002
Santiago de Compostela, Spain, 15706
Site TW88605
Tainan, Taiwan, Province of China, 710
Site IT39004
Pavia, Italy, 27100
Site US10008
Portland, United States, 97239
Site GB44007
Birmingham, United Kingdom, B15 2WB
Site ES34006
Cordoba, Spain, 14004
Site US10003
San Francisco, United States, 94115
Site US10002
Spartanburg, United States, 29303
Site ES34003
Barcelona, Spain, 08035
Site IT39001
Napoli, Italy, 80131
Site CA15001
Toronto, Canada, M5G2C4
Site CA15002
Montreal, Canada, H3T 1E2
Site KR82006
Seoul, Republic of Korea, 03080
Site US10009
Skokie, United States, 60077
Site IT39005
Benevento, Italy
Site US10015
Nashville, United States, 37208
Site IT39002
Milan, Italy, 20132
Site US10011
St. Louis, United States, 63104
Site ES34004
Madrid, Spain, 28222
Site US10001
San Juan, United States, 00927
Site US10021
Lebanon, United States, 03756-1000
Site GB44008
London, United Kingdom, W12 OHS
Site US10022
San Antonio, United States, 78215-1639
Site US10010
Columbus, United States, 43210
Site GB44005
Manchester, United Kingdom, M20 4BX
Site US10019
Philadelphia, United States, 19104
Site US10020
Evanston, United States, 60201
Site IT39008
Rozzano, Italy, 20089
Site HK85204
Shatin, Hong Kong, 999077
Site CA15003
Montreal, Canada, H4A 3J1
Site IT39006
Milano, Italy, 20122
Site US10014
Philadelphia, United States, 19104
Site HK85205
Tuen Mun, Hong Kong, 999077
Site US10016
Milwaukee, United States, 53226-3522
Site TW88603
Douliu, Taiwan, Province of China, 640
Site HK85202
Kowloon, Hong Kong, 999077
Site TW88604
Taipei City, Taiwan, Province of China, 10048
Site GB44004
London, United Kingdom, SE5 9RS
Site GB44002
Wirral, United Kingdom, CH63 4JY
Site KR82001
Seoul, Republic of Korea, 06591
Site KR82007
Seoul, Republic of Korea, 03722
Site IT39011
Padova, Italy, 35128
Site TW88606
Tainan, Taiwan, Province of China, 704
Site KR82005
Seoul, Republic of Korea, 135-710